Vaccine impedes the development of reflux-induced esophageal cancer in a surgical rat model: Efficacy of the vaccine in a post-barrett's esophagus setting

Digestive Diseases and Sciences

Volumn 53, Issue 11, 2008, Pages 2858-2867

  Miyashita, Tomoharu ^a   Shah, Furhawn A ^a   Marti, Guy P ^a   Armstrong, Todd D ^a   Wang, Jiaai ^a   Bonde, Pramod ^a   Gibson, Michael K ^a   Yoshimura, Kiyoshi ^a   Montgomery, Elizabeth A ^a   Duncan, Mark ^a   Jaffee, Elizabeth M ^a   Harmon, John W ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

Author keywords

Barrett's esophagus; Esophageal cancer; GM CSF; Vaccine

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TUMOR CELL VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BARRETT ESOPHAGUS; CANCER IMMUNIZATION; CANCER TRANSPLANTATION; CONTROLLED STUDY; DRUG EFFICACY; ESOPHAGUS CANCER; GASTROESOPHAGEAL REFLUX; IMMUNE RESPONSE; INJECTION SITE; NONHUMAN; PRIORITY JOURNAL; RAT; WHOLE CELL;

ADENOCARCINOMA; ANIMALS; BARRETT ESOPHAGUS; CANCER VACCINES; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; ESOPHAGEAL NEOPLASMS; ESOPHAGITIS, PEPTIC; ESOPHAGOSTOMY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; RATS; RATS, SPRAGUE-DAWLEY; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 53849101435     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-008-0232-z     Document Type: Article

References (22)

1. SH Landis T Murray S Bolden PA Wingo 1998 Cancer statistics, 1998 CA Cancer J Clin 48 6 29
2. SS Devesa WJ Blot JF Fraumeni Jr 1998 Changing patterns in the incidence of esophageal and gastric carcinoma in the united states Cancer 83 2049 2053
3. SH Landis T Murray S Bolden PA Wingo 1999 Cancer statistics, 1999 CA Cancer J Clin 49 8 31
4. MK Gibson AA Forastiere 2003 Combined-modality therapy for esophageal cancer: Are we making progress? Cancer J 9 238 240
5. CP Wild LJ Hardie 2003 Reflux, Barrett's oesophagus and adenocarcinoma: Burning questions Nat Rev Cancer 3 676 684
6. CK Byrnes A Bahadursingh N Akhter NL Parinandi V Natarajan E Montgomery T Tihan MD Duncan PH Nass JW Harmon 2003 Duodenal reflux produces hyperproliferative epithelial esophagitis-a possible precursor to esophageal adenocarcinoma in the rat J Gastrointest Surg 7 172 180
7. P Bonde G Sui S Dhara J Wang A Broor IF Kim JE Wiley G Marti M Duncan E Jaffee E Montgomery A Maitra JW Harmon 2007 Cytogentic characterization and gene expression profilling in the rat reflux induced esophageal tumor model J Thorac Cardiovasc Surg 133 763 769
8. NS Buttar KK Wang O Leontovich JY Westcott RJ Pacifico MA Anderson KK Krishnadath LS Lutzke LJ Burgart 2002 Chemoprevention of esophageal adenocarcinoma by cox-2 inhibitors in an animal model of Barrett's esophagus Gastroenterology 122 1101 1112
9. K Miwa H Sahara M Segawa S Kinami T Sato I Miyazaki T Hattori 1996 Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats Int J Cancer 67 269 274
10. G Dranoff E Jaffee A Lazenby P Golumbek H Levitsky K Brose V Jackson H Hamada D Pardoll RC Mulligan 1993 Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity Proc Natl Acad Sci USA 90 3539 3543
11. EM Jaffee RH Hruban B Biedrzycki D Laheru K Schepers PR Sauter M Goemann J Coleman L Grochow RC Donehower KD Lillemoe S O'Reilly RA Abrams DM Pardoll JL Cameron CJ Yeo 2001 Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: A phase i trial of safety and immune activation J Clin Oncol 19 145 156
12. LA Emens D Armstrong B Biedrzycki N Davidson J Davis-Sproul J Fetting E Jaffee B Onners S Piantadosi RT Reilly V Stearns I Tartakovsky K Visvanathan A Wolff 2004 A phase i vaccine safety and chemotherapy dose-finding trial of an allogeneic gm-csf-secreting breast cancer vaccine given in a specifically timed sequence with immunomodulatory doses of cyclophosphamide and doxorubicin Hum Gene Ther 15 313 337
13. JW Simons EM Jaffee CE Weber HI Levitsky WG Nelson MA Carducci AJ Lazenby LK Cohen CC Finn SM Clift KM Hauda LA Beck KM Leiferman AH Owens Jr S Piantadosi G Dranoff RC Mulligan DM Pardoll FF Marshall 1997 Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer Cancer Res 57 1537 1546
14. JW Simons B Mikhak JF Chang AM DeMarzo MA Carducci M Lim CE Weber AA Baccala MA Goemann SM Clift DG Ando HI Levitsky LK Cohen MG Sanda RC Mulligan AW Partin HB Carter S Piantadosi FF Marshall WG Nelson 1999 Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer Cancer Res 59 5160 5168
15. R Soiffer T Lynch M Mihm K Jung C Rhuda JC Schmollinger FS Hodi L Liebster P Lam S Mentzer S Singer KK Tanabe AB Cosimi R Duda A Sober A Bhan J Daley D Neuberg G Parry J Rokovich L Richards J Drayer A Berns S Clift LK Cohen RC Mulligan G Dranoff 1998 Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma Proc Natl Acad Sci USA 95 13141 13146
16. MF Reed G Tolis Jr BH Edil JS Allan DM Donahue HA Gaissert AC Moncure JC Wain CD Wright DJ Mathisen 2005 Surgical treatment of esophageal high-grade dysplasia Ann Thorac Surg 79 1110 1115 discussion 1110-1115
17. EA Davis RF Heitmiller 1996 Esophagectomy for benign disease: Trends in surgical results and management Ann Thorac Surg 62 369 372
18. MH Johnston 2005 Technology insight: Ablative techniques for Barrett's esophagus-current and emerging trends Nat Clin Pract Gastroenterol Hepatol 2 323 330
19. T Miyashita T Ohta T Fujimura I Ninomiya S Fushida T Hattori K Miwa 2006 Duodenal juice stimulates oesophageal stem cells to induce Barrett's oesophagus and oesophageal adenocarcinoma in rats Oncol Rep 15 1469 1475
20. G Sui P Bonde S Dhara A Broor J Wang G Marti G Feldmann M Duncan E Montgomery A Maitra JW Harmon 2006 Epidermal growth factor receptor and hedgehog signaling pathways are active in esophageal cancer cells from rat reflux model J Surg Res 134 1 1 9
21. Miyashita T, Shah F, Marti G, Armstrong TD, Wang J, Bonde P, Gibson MK, Yoshimura K, Montgomery EA, Duncan M, Jaffee EM, Harmon JW (2007) Vaccine impedes the development of reflux induced esophageal cancer in a surgical rat model: Efficacy of the vaccine in a pre-Barrett's esophagus setting. J Gastrointest Surg 12(1):1-9
22. MC Thomas TF Greten DM Pardoll EM Jaffee 1998 Enhanced tumor protection by granulocyte-macrophage colony-stimulating factor expression at the site of an allogeneic vaccine Hum Gene Ther 9 835 843